JAN MICHAEL VINCENT DIAZ: Open Payments
NPI 1023570090 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$350 in 16 payments from 8 companies in 2025. Trend: 2023 $202 · 2024 $372 · 2025 $350
Food & beverage: $350
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 3 | $60 |
| Janssen Pharmaceuticals, Inc | 2 | $57 |
| Neurocrine BioSciences, Inc. | 3 | $52 |
| Almatica Pharma LLC | 3 | $52 |
| Otsuka America Pharmaceutical, Inc. | 2 | $46 |
| E.R. Squibb & Sons, L.L.C. | 1 | $38 |
| Alkermes, Inc. | 1 | $27 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
Products named: Auvelity, SPRAVATO, INGREZZA, LOREEV XR, COBENFY, REXULTI, ARISTADA, ABILIFY ASIMTUFII.
Industry payments across NV — which companies pay providers there.
